Adriamycin-Cyclophosphamide (AC) followed by Paclitaxel-Cisplatin (PC). A highly active neoadjuvant regimen in locally advanced breast cancer

Detalles Bibliográficos
Autores principales: Mendoza-Posada, Daniel, Vela-Chavez, Teresa, Bargallo-Rocha, Enrique, Villafañe, Nestor, Gamboa-Vignole, Carlos, Arce, Claudia
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796552/
https://www.ncbi.nlm.nih.gov/pubmed/17291331
http://dx.doi.org/10.1186/1471-2407-7-S1-A1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796552/
https://www.ncbi.nlm.nih.gov/pubmed/17291331
http://dx.doi.org/10.1186/1471-2407-7-S1-A1

Ejemplares similares